Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Human Genome Epidemiology Literature Finder|Home|PHGKB

Human Genome Epidemiology Literature Finder


Last data update: Nov 8, 2024. (Total: 233355Documents)
   dataset        GWAS Only
Filtered By:

Previous    

Records 1 - 8 (of 8 Records)

Query Trace: Thrombocytosis and SF3B1[original query]
Age, JAK2(V617F) and SF3B1 mutations are the main predicting factors for survival in refractory anaemia with ring sideroblasts and marked thrombocytosis.
Leukemia 2013 Sep 27 (9): 1826-31.
Broséus J, Alpermann T, Wulfert M, Florensa Brichs L, Jeromin S, Lippert E, Rozman M, Lifermann F, Grossmann V, Haferlach T, Germing U, Luño E, Girodon F, Schnittger S,
Predictors of survival in refractory anemia with ring sideroblasts and thrombocytosis (RARS-T) and the role of next-generation sequencing.
American journal of hematology 2016 Feb .
Patnaik Mrinal M, Lasho Terra L, Finke Christy M, Hanson Curtis A, King Rebecca L, Ketterling Rhett P, Gangat Naseema, Tefferi Ayal
[The genetic characteristics of BCR-ABL-negative myeloproliferative neoplasms].
Zhonghua nei ke za zhi 2019 12 59 (1): 35-39.
Lyu X D, Li Y W, Guo Z, Xin Y P, Hu J Y, Fan R H, Song Y
Molecular landscape and clonal architecture of adult myelodysplastic/myeloproliferative neoplasms.
Blood 2020 6 136 (16): 1851-1862.
Palomo Laura, Meggendorfer Manja, Hutter Stephan, Twardziok Sven, Ademà Vera, Fuhrmann Irene, Fuster-Tormo Francisco, Xicoy Blanca, Zamora Lurdes, Acha Pamela, Kerr Cassandra M, Kern Wolfgang, Maciejewski Jaroslaw P, Solé Francesc, Haferlach Claudia, Haferlach Torst
Clinicopathologic characterisation of myeloid neoplasms with concurrent spliceosome mutations and myeloproliferative-neoplasm-associated mutations.
Journal of clinical pathology 2020 3 73 (11): 728-736.
Liu Yen-Chun, Illar Gwendolyn M, Bailey Nathanael Gl
Myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T): Mayo-Moffitt collaborative study of 158 patients.
Blood cancer journal 2022 2 12 (2): 26.
Mangaonkar Abhishek A, Lasho Terra L, Ketterling Rhett P, Reichard Kaaren K, Gangat Naseema, Al-Kali Aref, Begna Kebede H, Pardanani Animesh, Al Ali Najla H, Talati Chetasi, Sallman David, Padron Eric, Patnaik Mrinal M, Tefferi Ayalew, Komrokji Ra
Genomic Landscape of Myelodysplastic/Myeloproliferative Neoplasms: A Multi-Central Study.
International journal of molecular sciences 2024 9 25 (18): .
Fei Fei, Amar Jariwala, Sheeja Pullarkat, Eric Loo, Yan Liu, Parastou Tizro, Haris Ali, Salman Otoukesh, Idoroenyi Amanam, Andrew Artz, Feras Ally, Milhan Telatar, Ryotaro Nakamura, Guido Marcucci, Michelle Afkha
Predicting survival in patients with myelodysplastic/myeloproliferative neoplasms with SF3B1 mutation and thrombocytosis.
Leukemia 2024 5 .
Fuhui Li, Tiejun Qin, Bing Li, Shiqiang Qu, Lijuan Pan, Peihong Zhang, Qi Sun, Wenyu Cai, Qingyan Gao, Meng Jiao, Junjie Li, Xiaofei Ai, Jiao Ma, Robert Peter Gale, Zefeng Xu, Zhijian Xi
TOP